Download Citation
Article Source:
Rapamycin Enhances the Anti-Cancer Effect of Dasatinib by Suppressing Src/PI3K/mTOR Pathway in NSCLC Cells
Chen B,
Xu X,
Luo J,
Wang H,
Zhou S
(2015)
Rapamycin Enhances the Anti-Cancer Effect of Dasatinib by Suppressing Src/PI3K/mTOR Pathway in NSCLC Cells.
PLOS ONE 10(6): e0129663.
https://doi.org/10.1371/journal.pone.0129663